Dai Ichi Life Holdings Stock Revenue
| DCNSFDelisted Stock | USD 25.48 0.00 0.00% |
Dai ichi Life Holdings fundamentals help investors to digest information that contributes to Dai-ichi Life's financial success or failures. It also enables traders to predict the movement of Dai-ichi Pink Sheet. The fundamental analysis module provides a way to measure Dai-ichi Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dai-ichi Life pink sheet.
Dai-ichi |
Dai ichi Life Holdings Company Revenue Analysis
Dai-ichi Life's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Dai-ichi Life Revenue | 7.86 T |
Most of Dai-ichi Life's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dai ichi Life Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Dai ichi Life Holdings reported 7.86 T of revenue. This is much higher than that of the Financial Services sector and significantly higher than that of the Insurance—Life industry. The revenue for all United States stocks is significantly lower than that of the firm.
Dai-ichi Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dai-ichi Life's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Dai-ichi Life could also be used in its relative valuation, which is a method of valuing Dai-ichi Life by comparing valuation metrics of similar companies.Dai Ichi is currently under evaluation in revenue category among its peers.
Dai-ichi Fundamentals
| Return On Equity | 0.0854 | |||
| Return On Asset | 0.0032 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 11.66 B | |||
| Shares Outstanding | 1.03 B | |||
| Shares Owned By Insiders | 4.71 % | |||
| Shares Owned By Institutions | 50.27 % | |||
| Price To Earning | 28.81 X | |||
| Price To Book | 0.80 X | |||
| Price To Sales | 0 X | |||
| Revenue | 7.86 T | |||
| Gross Profit | 1.44 T | |||
| EBITDA | 427.44 B | |||
| Net Income | 409.35 B | |||
| Cash And Equivalents | 2.21 T | |||
| Total Debt | 870.38 B | |||
| Debt To Equity | 0.25 % | |||
| Current Ratio | 2.62 X | |||
| Book Value Per Share | 2,881 X | |||
| Cash Flow From Operations | (462.08 B) | |||
| Earnings Per Share | 2.45 X | |||
| Price To Earnings To Growth | 22.35 X | |||
| Number Of Employees | 61.9 K | |||
| Beta | 0.69 | |||
| Market Capitalization | 31.53 B | |||
| Total Asset | 65.88 T | |||
| Retained Earnings | 545.4 B | |||
| Working Capital | 468.62 B | |||
| Current Asset | 1.56 T | |||
| Current Liabilities | 1.09 T | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 65.88 T | |||
| Last Dividend Paid | 83.0 |
About Dai-ichi Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dai ichi Life Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dai-ichi Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dai ichi Life Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Dai-ichi Pink Sheet
If you are still planning to invest in Dai ichi Life check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dai-ichi Life's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |